Distinct roles of different NF-kappa B subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells - PubMed (original) (raw)
Comparative Study
. 2007 Jun 1;178(11):6777-88.
doi: 10.4049/jimmunol.178.11.6777.
Affiliations
- PMID: 17513725
- DOI: 10.4049/jimmunol.178.11.6777
Comparative Study
Distinct roles of different NF-kappa B subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells
Junmei Wang et al. J Immunol. 2007.
Abstract
TLRs play a critical role in inducing inflammatory and immune responses against microbial agents. In this study, we have investigated the role of NF-kappaB transcription factors in regulating TLR-induced gene expression in dendritic cells, a key APC type. The p50 and cRel NF-kappaB subunits were found to be crucial for regulating genes important for dendritic cell-induced T cell responses (e.g., CD40, IL-12, and IL-18) but not for genes encoding inflammatory cytokines (e.g., TNF-alpha, IL-1alpha, and IL-6). In striking contrast, the RelA subunit was crucial for expression of inflammatory cytokine genes but not T cell stimulatory genes. These novel findings reveal a fundamentally important difference in biological function of genes regulated by different NF-kappaB subunits. Focusing on RelA target gene specificity mechanisms, we investigated whether the kappaB site and/or the unique composition of RelA played the most crucial role. Surprisingly, studies of IL-6 expression showed that the kappaB site is not a primary determinant of RelA target gene specificity. Instead, a major specificity mechanism is the unique ability of RelA to interact with the transcriptional coactivator CREB-binding protein, a function not shared with the closely related cRel subunit. Together, our findings indicate novel and critically important overall roles of NF-kappaB in TLR-induced gene expression that are mediated by unique functions of distinct subunits.
Similar articles
- Lack of essential role of NF-kappa B p50, RelA, and cRel subunits in virus-induced type 1 IFN expression.
Wang X, Hussain S, Wang EJ, Wang X, Li MO, García-Sastre A, Beg AA. Wang X, et al. J Immunol. 2007 Jun 1;178(11):6770-6. doi: 10.4049/jimmunol.178.11.6770. J Immunol. 2007. PMID: 17513724 - Dendritic cell development and survival require distinct NF-kappaB subunits.
Ouaaz F, Arron J, Zheng Y, Choi Y, Beg AA. Ouaaz F, et al. Immunity. 2002 Feb;16(2):257-70. doi: 10.1016/s1074-7613(02)00272-8. Immunity. 2002. PMID: 11869686 - EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation.
Wirtz S, Becker C, Fantini MC, Nieuwenhuis EE, Tubbe I, Galle PR, Schild HJ, Birkenbach M, Blumberg RS, Neurath MF. Wirtz S, et al. J Immunol. 2005 Mar 1;174(5):2814-24. doi: 10.4049/jimmunol.174.5.2814. J Immunol. 2005. PMID: 15728491 - NF-κB: roles and regulation in different CD4(+) T-cell subsets.
Oh H, Ghosh S. Oh H, et al. Immunol Rev. 2013 Mar;252(1):41-51. doi: 10.1111/imr.12033. Immunol Rev. 2013. PMID: 23405894 Free PMC article. Review. - NF-κB as a target for modulating inflammatory responses.
Gasparini C, Feldmann M. Gasparini C, et al. Curr Pharm Des. 2012;18(35):5735-45. doi: 10.2174/138161212803530763. Curr Pharm Des. 2012. PMID: 22726116 Review.
Cited by
- PIKfyve, expressed by CD11c-positive cells, controls tumor immunity.
Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, Vatan L, Lin H, Li G, Zheng Y, Zhang Y, Cao X, Su F, Wang R, He T, Cieslik M, Green MD, Zou W, Chinnaiyan AM. Choi JE, et al. Nat Commun. 2024 Jun 28;15(1):5487. doi: 10.1038/s41467-024-48931-9. Nat Commun. 2024. PMID: 38942798 Free PMC article. - Genetic polymorphisms, biomarkers and signaling pathways associated with septic shock: from diagnosis to therapeutic targets.
Wu M, Mi B, Liu L, Ma H, Jiang C, Jiang S, Li Y, Zhao Y. Wu M, et al. Burns Trauma. 2024 May 6;12:tkae006. doi: 10.1093/burnst/tkae006. eCollection 2024. Burns Trauma. 2024. PMID: 38716051 Free PMC article. Review. - PIKfyve controls dendritic cell function and tumor immunity.
Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, Vatan L, Lin H, Li G, Zheng Y, Zhang Y, Cao X, Su F, Wang R, He T, Cieslik M, Green MD, Zou W, Chinnaiyan AM. Choi JE, et al. bioRxiv [Preprint]. 2024 Jul 1:2024.02.28.582543. doi: 10.1101/2024.02.28.582543. bioRxiv. 2024. PMID: 38464258 Free PMC article. Updated. Preprint. - Histone Deacetylase Inhibitors Directly Modulate T Cell Gene Expression and Signaling and Promote Development of Effector-Exhausted T Cells in Murine Tumors.
Ibrahim ML, Zheng H, Barlow ML, Latif Y, Chen Z, Yu X, Beg AA. Ibrahim ML, et al. J Immunol. 2024 Feb 15;212(4):737-747. doi: 10.4049/jimmunol.2300475. J Immunol. 2024. PMID: 38169329 - Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity.
Zheng H, Yu X, Ibrahim ML, Foresman D, Xie M, Johnson JO, Boyle TA, Ruffell B, Perez BA, Antonia SJ, Ready N, Saltos AN, Cantwell MJ, Beg AA. Zheng H, et al. Cancer Immunol Res. 2023 Apr 3;11(4):466-485. doi: 10.1158/2326-6066.CIR-22-0927. Cancer Immunol Res. 2023. PMID: 36757308 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous